AdE1-LMP poly adenovirus-based adoptive immunotherapy resulted in expansion of EBV-specific T cells. Overall survival of NPC patients were increased with mild toxicities. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.